ALS – JoelGalvan

Business

Prilenia signs deal for former Teva ALS drug worth up to 500m

5 min read

Posted on April 29, 2025

by Joelgalvan

Israeli-Dutch clinical stage biotech company Prilenia Therapeutics has announced a collaboration and licensing agreement for its lead drug Pridopidine,…

JoelGalvan

Tag: ALS

Prilenia signs deal for former Teva ALS drug worth up to 500m

Recent Posts

Recent Comments

Archives

Categories